C71.5
Malignant neoplasm of cerebral ventricle
Clinical Classification Guidelines
Excludes Type 1
- malignant neoplasm of fourth cerebral ventricle (C71.7)
Medical Intelligence & Overview
Malignant neoplasm of the cerebral ventricle refers to an aggressive type of brain tumor that originates within the ventricles of the brain. These ventricles are a system of interconnected cavities filled with cerebrospinal fluid, helping to protect the brain and maintain its chemical environment. Such tumors are classified as primary brain cancers, meaning they start in the brain rather than spreading from other parts of the body. Due to their location and aggressive nature, malignant neoplasms of the cerebral ventricle require careful diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting cell growth and division Certain hereditary conditions that increase tumor risk Exposure to high doses of radiation or carcinogens Family history of brain tumors Unknown factors; research is ongoing to identify specific causes
Key Symptoms: Persistent headaches Nausea and vomiting Vision changes or blurred vision Difficulty with balance or coordination Changes in mental state or personality Seizures Problems with speech or movement Weakness or numbness in limbs
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of the cerebral ventricle typically involves a combination of medical imaging and neurological assessments. Common diagnostic procedures include: - Magnetic Resonance Imaging (MRI): Provides detailed images of the brain to locate tumors and assess their size and spread. - Computed Tomography (CT) scan: Often used initially to detect abnormalities. - Biopsy: A sample of tumor tissue may be taken to confirm malignancy and determine the tumor type. - Additional tests: May include neurological exams and other imaging studies to evaluate the extent of the disease.
Treatment Protocols: Treatment strategies are tailored based on tumor size, location, patient's overall health, and other factors. Common approaches include: - Surgery: The primary treatment for accessible tumors, aiming to remove as much of the tumor as possible. - Radiation therapy: Uses high-energy beams to destroy cancer cells and shrink remaining tumor tissue. - Chemotherapy: Uses drugs to target and kill cancer cells, often administered alongside other therapies. - Supportive care: Includes medications to manage symptoms such as swelling, seizures, and pain. - Clinical trials: Patients may have access to experimental therapies or novel approaches through research studies.
Clinical Advice & FAQs
Billing Guidance
Is C71.5 a billable ICD-10 code?
Yes, C71.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C71.5?
Clinical documentation must specify the nature of Malignant neoplasm of cerebral ventricle and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
